- Home
- SILO vs SXTP Comparison
SILO vs SXTP Comparison
Compare SILO & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- SXTP
- Stock Information
- Founded
- SILO 2010
- SXTP 2010
- Country
- SILO United States
- SXTP United States
- Employees
- SILO N/A
- SXTP N/A
- Industry
- SILO Apparel
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- SXTP Health Care
- Exchange
- SILO Nasdaq
- SXTP Nasdaq
- Market Cap
- SILO 8.0M
- SXTP 6.7M
- IPO Year
- SILO N/A
- SXTP 2023
- Fundamental
- Price
- SILO $0.54
- SXTP $1.36
- Analyst Decision
- SILO
- SXTP Buy
- Analyst Count
- SILO 0
- SXTP 2
- Target Price
- SILO N/A
- SXTP $3.00
- AVG Volume (30 Days)
- SILO 869.8K
- SXTP 286.8K
- Earning Date
- SILO 11-12-2025
- SXTP 11-14-2025
- Dividend Yield
- SILO N/A
- SXTP N/A
- EPS Growth
- SILO N/A
- SXTP N/A
- EPS
- SILO N/A
- SXTP N/A
- Revenue
- SILO $72,102.00
- SXTP $984,494.00
- Revenue This Year
- SILO $1.86
- SXTP $81.41
- Revenue Next Year
- SILO N/A
- SXTP $83.17
- P/E Ratio
- SILO N/A
- SXTP N/A
- Revenue Growth
- SILO N/A
- SXTP 128.70
- 52 Week Low
- SILO $0.40
- SXTP $1.22
- 52 Week High
- SILO $3.37
- SXTP $12.45
- Technical
- Relative Strength Index (RSI)
- SILO 40.10
- SXTP 41.48
- Support Level
- SILO $0.50
- SXTP $1.43
- Resistance Level
- SILO $0.59
- SXTP $1.52
- Average True Range (ATR)
- SILO 0.05
- SXTP 0.11
- MACD
- SILO -0.00
- SXTP -0.02
- Stochastic Oscillator
- SILO 54.31
- SXTP 2.04
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.